Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
3.680
0.00 (0.00%)
At close: Oct 23, 2026, 4:00 PM EDT
3.670
-0.010 (-0.27%)
After-hours: Oct 23, 2026, 7:30 PM EDT
Fulcrum Therapeutics Employees
Fulcrum Therapeutics had 9 employees as of June 30, 2026. The number of employees decreased by 46 or 83.64% since the number was reported on December 31, 2025. That makes Fulcrum Therapeutics the 40,599th largest employer in the world and 6,127th in the United States.
Employees
9
Change
-46
Growth
-83.64%
Revenue / Employee
n/a
Profits / Employee
-$9,444,333
Market Cap
280.77M
Employees Chart
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 9 | -46 | -83.64% |
| Dec 31, 2025 | 55 | 10 | 22.22% |
| Dec 31, 2024 | 45 | -31 | -40.79% |
| Dec 31, 2023 | 76 | -13 | -14.61% |
| Dec 31, 2022 | 89 | -15 | -14.42% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Artiva Biotherapeutics | 115 |
| Arcturus Therapeutics Holdings | 111 |
| Alector | 103 |
| SAB Biotherapeutics | 86 |
| Scribe Therapeutics | 82 |
| Agenus | 81 |
| Century Therapeutics | 78 |
| Inhibikase Therapeutics | 35 |
FULC News
- 15 days ago - Kaplan Fox is Investigating Claims Against Fulcrum Therapeutics, Inc. (FULC) on Behalf of Investors - Newsfile Corp
- 17 days ago - Kaplan Fox Encourages Fulcrum Therapeutics, Inc. (FULC) Investors Who Suffered Losses to Learn About Their Legal Rights - Newsfile Corp
- 25 days ago - Kaplan Fox Notifies Fulcrum Therapeutics, Inc. (FULC) Investors of a Pending Securities Investigation - Newsfile Corp
- 4 weeks ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Centerspace (NYSE – CSR), Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Personalis, Inc. (Nasdaq – PSNL) - GlobeNewsWire
- 5 weeks ago - Kaplan Fox Encourages Investors of Fulcrum Therapeutics, Inc. (FULC) to Learn More About the Firm's Investigation - Newsfile Corp
- 5 weeks ago - Kaplan Fox is Investigating Fulcrum Therapeutics, Inc. (FULC) for Investors Who Suffered Losses - Newsfile Corp
- 6 weeks ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Centerspace (NYSE – CSR), Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Bio-Techne Corporation (Nasdaq – TECH) - GlobeNewsWire
- 6 weeks ago - Kaplan Fox Reminds Investors of Fulcrum Therapeutics, Inc. (FULC) of an Ongoing Securities Investigation - Newsfile Corp